by Bill Malloy | Jul 13, 2022 | Uncategorized
A study recently published in the journal of European Urology Oncology has found a link between microbiomes in the urine and the development of several forms of cancer, especially advanced prostate cancer. The findings of this study suggest that five different types...
by Bill Malloy | Jul 5, 2022 | Uncategorized
A recent study at Sweden’s Karolinska Institute has revealed that a protein called GIT1 has shown the ability to protect against the growth of estrogen receptor-negative breast tumors. This type of breast cancer is among the most difficult variations to treat, and the...
by Bill Malloy | Jun 29, 2022 | Uncategorized
A clinical trial at the University of Cincinnati has found that adding a newly developed immunotherapy drug to standard treatment methods could improve survival rates for head and neck cancer patients. The trial was led by Trisha Wise-Draper, MD, and published in the...
by Bill Malloy | Jun 13, 2022 | Uncategorized
An international study researching innovations in the treatment of colorectal cancer was bolstered in early February by a five-year renewal and $10 million in new funding. Based at the Huntsman Cancer Institute at the University of Utah, the ColoCare Study commenced...
by Bill Malloy | Jun 6, 2022 | Uncategorized
A team of stem cell scientists from Cedars-Sinai Medical Center in Los Angeles recently made two discoveries that could have major implications for cancer treatment. Researchers in the first study made a discovery that could drastically improve the efficiency of...
by Bill Malloy | May 9, 2022 | Health, Pharmaceuticals, Scientists, Uncategorized
A potential cancer immunotherapy treatment has been developed by researchers at Purdue University’s College of Pharmacy. Led by Zhong-Yin Zhang, the researchers are continuing to develop the immunotherapy treatment, which is based on an enzyme mutation. The team of...
